PMH17 COST-EFFECTIVENESS OF LONG ACTING METHYLPHENIDATE-OROS IN ADHD YOUTHS WITH SUBOPTIMAL SYMPTOM CONTROL ON IMMEDIATE-RELEASE METHYLPHENIDATE IN THE NETHERLANDS
Abstract
Authors
A Faber M Van Agthoven L Kalverdijk H Tobi L De Jong van den Berg L Annemans MJ Postma